We are delighted to announce the introduction of the FOCUS4-C comparison to the FOCUS4 Trial Programme, which has received MHRA, HRA and Ethics approvals. We have also removed the high platelets exclusion criterion from the Master Protocol and made some other eligibility changes.
For information on how you can process this amendment and activate your site to FOCUS4-C, please see the Activation Notification document, which was e-mailed to all sites and is also found in the Investigators Area. The substantial amendment documents and new template documents can be found in the Investigators Area of our website.
The primary research objectives fall into 3 main categories:
Access all the required documentation for site set-up such as: :
FOCUS4 aims to register 2400 and randomise at least 1536 patients from over 100 hospitals across the whole of the UK.
FOCUS4 started recruitment in January 2014, and is currently open to recruitment
There are 103 sites open in the UK recruiting to FOCUS4.
Trial Committees and Investigators
There are a number of committees involved with the oversight of the trial.